Literature DB >> 18381646

The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease.

David J Gill1, Arielle Freshman1, Jennifer A Blender2, Bernard Ravina1.   

Abstract

Cognitive impairment is common in Parkinson's disease (PD) and can occur early in the disease course. No effective screening test exists for detection of early or mild cognitive impairment in PD. We examined the Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive dysfunction in PD. The test-retest intraclass correlation coefficient was 0.79 and the interrater intraclass correlation coefficient was 0.81. The correlation coefficient between the MoCA and a neuropsychologic battery was 0.72. The MoCA is reliable and valid in the PD population and warrants further study as a screening tool for cognitive dysfunction.

Entities:  

Mesh：

Year:  2008        PMID： 18381646     DOI： 10.1002/mds.22017

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  109 in total

Review 1.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

2.  Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCA.

Authors:  B Hanna-Pladdy; A Enslein; M Fray; B J Gajewski; R Pahwa; K E Lyons
Journal:  Int J Neurosci       Date:  2010-08       Impact factor: 2.292

Review 3.  Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.

Authors:  Katherine Leaver; Kathleen L Poston
Journal:  Neuropsychol Rev       Date:  2015-12-01       Impact factor: 7.444

4.  A recommended scale for cognitive screening in clinical trials of Parkinson's disease.

Authors:  Kelvin L Chou; Melissa M Amick; Jason Brandt; Richard Camicioli; Karen Frei; Darren Gitelman; Jennifer Goldman; John Growdon; Howard I Hurtig; Bonnie Levin; Irene Litvan; Laura Marsh; Tanya Simuni; Alexander I Tröster; Ergun Y Uc
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

5.  Adaptation and psychometric properties of the Italian version of the Non-Motor Symptoms Questionnaire for Parkinson's disease.

Authors:  I Cova; M E Di Battista; N Vanacore; C P Papi; G Alampi; A Rubino; M Valente; G Meco; P Contri; A Di Pucchio; E Lacorte; A Priori; C Mariani; S Pomati
Journal:  Neurol Sci       Date:  2017-02-01       Impact factor: 3.307

Review 6.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

7.  Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease.

Authors:  Daniel S Brown; Ira H Bernstein; Shawn M McClintock; C Munro Cullum; Richard B Dewey; Mustafa Husain; Laura H Lacritz
Journal:  Int J Geriatr Psychiatry       Date:  2015-07-14       Impact factor: 3.485

8.  Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.

Authors:  Sarra Nazem; Andrew D Siderowf; John E Duda; Tom Ten Have; Amy Colcher; Stacy S Horn; Paul J Moberg; Jayne R Wilkinson; Howard I Hurtig; Matthew B Stern; Daniel Weintraub
Journal:  J Am Geriatr Soc       Date:  2008-12-10       Impact factor: 5.562

9.  Normative Data for the Montreal Cognitive Assessment in Middle-Aged and Elderly Quebec-French People.

Authors:  Eddy Larouche; Marie-Pier Tremblay; Olivier Potvin; Sophie Laforest; David Bergeron; Robert Laforce; Laura Monetta; Linda Boucher; Pascale Tremblay; Sylvie Belleville; Dominique Lorrain; Jean-François Gagnon; Nadia Gosselin; Christian-Alexandre Castellano; Stephen C Cunnane; Joël Macoir; Carol Hudon
Journal:  Arch Clin Neuropsychol       Date:  2016-11-22       Impact factor: 2.813

10.  Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan.

Authors:  Shea Gluhm; Jody Goldstein; Kiet Loc; Alexandra Colt; Charles Van Liew; Jody Corey-Bloom
Journal:  Cogn Behav Neurol       Date:  2013-03       Impact factor: 1.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.